Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/1999
02/11/1999CA2294650A1 Starch debranching enzymes
02/11/1999CA2291944A1 Genetic method for controlling sprouting
02/11/1999CA2239836A1 Novel arginine deiminase
02/11/1999CA2239813A1 Novel nrdd
02/11/1999CA2239221A1 Novel his5
02/11/1999CA2225185A1 Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities
02/10/1999EP0896063A2 Method for the selection of genetically transformed cells and compounds for use in the method
02/10/1999EP0896062A2 Transformation of alkalophilic bacillus strains
02/10/1999EP0896061A2 RpoA gene from Staphylococcus aureus
02/10/1999EP0896060A2 RpoA gene from Staphylococcus aureus
02/10/1999EP0896059A2 Method for the production of pathogen resistant plants
02/10/1999EP0896058A1 Novel semaphorin z and gene encoding the same
02/10/1999EP0896056A1 Novel thermolysin-like protease and use thereof
02/10/1999EP0896055A2 Apoptosis inducing protein and gene encoding the same
02/10/1999EP0896002A1 Chimeric proteins, heterodimer complexes thereof and substitute for platelet
02/10/1999EP0895546A1 Methods of isolating biological target materials using silica magnetic particles
02/10/1999EP0895545A1 Novel protein - traf6
02/10/1999EP0895544A1 Method, apparatus and kits for sequencing of nucleic acids using multiple dyes
02/10/1999EP0895543A1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens
02/10/1999EP0895542A1 Derived tyrosine hydroxylase gene expression system
02/10/1999EP0895541A1 Non antibiotic selectable markers for live vaccines
02/10/1999EP0895540A1 Fruit ripening
02/10/1999EP0895539A2 Secreted proteins and polynucleotides encoding them
02/10/1999EP0895538A1 Mutated ras peptides for generation of cd8?+ cytotoxic t lymphocytes
02/10/1999EP0895536A2 Isolation of enzymes
02/10/1999EP0763133A4 Method for detecting a target nucleic acid
02/10/1999EP0752878A4 Products comprising substrates capable of enzymatic cross-linking
02/10/1999EP0597843B1 16 kDa SURFACE PROTEIN OF P. FALCIPARUM
02/10/1999EP0408690B1 L-malic acid degrading yeast for wine making
02/10/1999CN1207810A Storage-stable particle, in particular carrier for carrier-bound reactions, and methods of producing said particle
02/10/1999CN1207775A Conditionally replicating viral vectors and their use
02/10/1999CN1207774A Method for gene introduction into target cells by retrovirus
02/10/1999CN1207773A Vector for expression of N-terminally extended proteins in yeast cell
02/10/1999CN1207772A Modification process
02/10/1999CN1207771A Methods and compositions for diagnosis and treatment of cancer
02/10/1999CN1207769A Tissue-specific and target RNA-specific ribozymes
02/10/1999CN1207768A Nucleic acid molecule encoding 11-cis retinol dehydrogenase
02/10/1999CN1207686A FC 'epsilon'-PE chimeric protein for targeted treatment of allergy responses, method for its production and pharmaceutical compositions contg. same
02/10/1999CN1207653A Plate-shaped holder housing for daily use and/or consumer articles
02/10/1999CN1207645A Process for constructing temp.-tolerant plants
02/10/1999CN1207415A Recombinant fish growth hormone gene engrg. yeast pichia pastoris
02/10/1999CN1207414A Method for producing glucokinase by gene engrg. technique
02/10/1999CN1207395A Anti-FAS antibodies
02/09/1999US5869720 Transgenic cotton plants producing heterologous peroxidase
02/09/1999US5869719 Introducing a chimeric gene that expresses a sythetase or transferase used in the biosynthetic pathway of biotin, increased enzyme concentration resulting in increased biotin production
02/09/1999US5869718 Homologous recombination for animal model exhibiting reduced levels or elimination of a neuronal intermediate filament protein
02/09/1999US5869696 Universal solid supports and methods for their use
02/09/1999US5869644 Synthesis of diverse and useful collections of oligonucleotidies
02/09/1999US5869641 An isolated modified rna ligand that reacts like an anti-cd4 antibody; treating autoimmune diseases, hiv, antidiabetic and antiarthritic agents
02/09/1999US5869638 Bone-related cadherin-like protein and process for its production
02/09/1999US5869637 Human Kallikrein
02/09/1999US5869636 Recombinant cell line expressing polypetide for anticarcinogenic and antitumor agents and vaccines
02/09/1999US5869634 Method of making an RNA particle for use in cleaving nucleic acid molecules and inserting a nucleic acid molecule into the cleavage site
02/09/1999US5869633 Thrombin receptor homolog polynucleotide
02/09/1999US5869624 HIV-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof
02/09/1999US5869621 A human antibody, expressed in the thymus, that binds an at rich sequence proteins in the nuclear scaffold; unwinding properties in relieving negative superhelical strains that occur in chromatin loops; use as probe for atc sequences
02/09/1999US5869615 Analog proteins involved in alternative pathways of the immune system; therapuetic treatments of complement mediated disorders: autoimmune disease, suppress transplant rejections, aids in reduction of tissue damage
02/09/1999US5869612 Amino acid sequence of isolated protein involved in post-receptor signal transduction; treatment of rheumatoid arthritis and septic shock
02/09/1999US5869610 Isolated polypeptide identified as a cytokine receptor containing extracellular, transmembrane and intracellular domains; prenatal testing and cancer diagnosis
02/09/1999US5869609 G protein coupled glutamate receptors
02/09/1999US5869608 Nucleotide and amino acid sequences of the four variable domains of the major outer membrane proteins of Chlamydia trachomatis
02/09/1999US5869463 Use of neuro-glial cell lines for transplantation therapy
02/09/1999US5869462 Inhibition of proliferation of vascular smooth muscle cell
02/09/1999US5869453 Cytotoxic T-cell epitopes
02/09/1999US5869339 Host cell transformed with vector coding for synthetic rna catalyst for cleavage of rna substrate; for viricides and control of gene expression
02/09/1999US5869337 Regulated transcription of targeted genes and other biological events
02/09/1999US5869336 Insect cell viral expression system producing calcium activated neutral protease; treatment of alzheimer's, huntington's, parkinson's, muscular dystrophy and other central nervous system disorders
02/09/1999US5869333 Ryegrass pollen allergen
02/09/1999US5869331 Target cell specific chimeric spleen necrosis virus viral particles having antigenic binding and natural viral proteins; gene therapy
02/09/1999US5869326 Electroporation employing user-configured pulsing scheme
02/09/1999US5869320 Isolated dna sequence for efficient, selective high level biosynthesis of selected genes
02/09/1999US5869314 Tissue plasminogen activators and derivatives thereof as produced by recombinant means
02/09/1999US5869313 Dna fragments coding for envelope and regulatory proteins of hiv-1 strains common to united states; for vaccines and detection in blood samples
02/09/1999US5869312 Recombinant swinepox virus
02/09/1999US5869310 Pure agarlytic enzyme having rapid hydrolsis rates, active at high phs and in most electrophoretic buffers, exhibiting good thermal stability; for recovery of dna from agarose gels
02/09/1999US5869309 Cephalosporin esterase gene from Rhodosporidium toruloides
02/09/1999US5869307 Human GDP-mannose 4,6-dehydratase
02/09/1999US5869306 Gene transfer preparation
02/09/1999US5869305 Nucleic acid with adeno-associated virus inverted terminal repeat sequence and 20 basepair d sequence; for replication and assembly into viral particles and/or integration into host genome for gene therapy
02/09/1999US5869302 Analog of haemophilus hin47 with reduced protease activity
02/09/1999US5869301 Method for the production of dicarboxylic acids
02/09/1999US5869299 Using an enzyme system from streptomyces, particularly s. clavuligerus.
02/09/1999US5869298 Stable mutants of D-N-α-carbamoylase and process for preparing D-α-amino acids
02/09/1999US5869296 Increasing rna transcription of genes adjacent to strong bacteriophage promoters by insertion of nucleotide sequence of transposon
02/09/1999US5869295 Synthesizing nucleotide sequences coding for functional polypeptides coupled to flanking constant regions containing restriction enzyme sites; where nucleotides from mixture of predetermined proportions based on amino acid profile
02/09/1999US5869294 Method for stably cloning large repeating DNA sequences
02/09/1999US5869293 DNA encoding human interferon IFN -α001
02/09/1999US5869292 Producing genetically engineered protein by replacing at least one acidic region of factor viii with acidic region of hirudin or heparin cofactor ii; increased coagulant activity
02/09/1999US5869290 Cayae1 polynucleotides
02/09/1999US5869287 Method of producing particles containing nucleic acid sequences in yeast
02/09/1999US5869286 Receptor that binds IL-17
02/09/1999US5869284 Polynucleotide for gene expression in cultures; for tissue regeneration, stimulation of immune and hematopoeitic systems, modulators of receptor activity
02/09/1999US5869283 Expression cassette operable in a recombinant host
02/09/1999US5869282 Nucleotide and protein sequences of the serrate gene and methods based thereon
02/09/1999US5869281 For culturing and screening for modulators of receptor; glucoma, synchronization of animal estrus cycles, antitumor and antiprolferative agents
02/09/1999US5869278 Process for the preparation of mature human growth hormone by enzymatic hydrolysis of a soluble precursor with immobilized factor Xa
02/09/1999US5869271 G-beta-gamma regulated phosphatidylinositol-3' kinase
02/09/1999US5869270 Single chain MHC complexes and uses thereof
02/09/1999US5869268 Anti-hanganutzui-deicher human monoclonal igg antibody; for anticarcinogenic and antitumors agents and diagnosis
02/09/1999US5869265 Screening modulators by contacting recombinant cells which express cotransporter with substance, determining increase or decrease in activity; anticholesterol agents; antidiabetic agents; liver disease; crohn's disease